Morphological change and destabilization of beta-actin mRNA by tumor necrosis factor in human microvascular endothelial cells

Exp Cell Res. 1993 Oct;208(2):498-503. doi: 10.1006/excr.1993.1272.

Abstract

Tumor necrosis factor-alpha (TNF-alpha) produced morphological changes from a cobblestone-like shape into a spindle shape in human omental microvascular endothelial (HOME) cells and also a drastic rearrangement of actin filaments. Expression of beta-actin gene was diminished in HOME cells treated with TNF-alpha for 24 h. Northern blot analysis of the beta-actin gene demonstrated that the cellular level of beta-actin mRNA was decreased at 6-12 h after exposure to TNF-alpha. However, there appeared to be no changes in cellular mRNA levels of beta-tubulin, fibronectin, laminin B1, laminin B2, and laminin binding protein genes after treatment with TNF-alpha. Nuclear run-on assays showed increased transcription of the low-density lipoprotein receptor gene, but not of the beta-actin gene. These data suggested that the TNF-alpha-induced inhibition of beta-actin gene expression was not due to altered transcription activity. The degradation rates of beta-actin, plasminogen activator inhibitor-1, and epidermal growth factor receptor mRNAs were examined in the presence of actinomycin D. beta-Actin mRNA was found to be specifically destabilized in TNF-alpha-treated HOME cells, while other mRNA species were not. Coadministration of cycloheximide blocked the TNF-alpha-induced degradation of beta-actin mRNA. The TNF-alpha-induced destabilization of beta-actin mRNA and rearrangement of actin filaments are discussed in relation to the morphological changes in human microvascular endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Cytoskeleton / ultrastructure
  • Actins / genetics*
  • Cytoskeletal Proteins / genetics
  • Endothelium, Vascular / metabolism*
  • Extracellular Matrix Proteins / genetics
  • Gene Expression / drug effects
  • Humans
  • In Vitro Techniques
  • RNA, Messenger / genetics
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Actins
  • Cytoskeletal Proteins
  • Extracellular Matrix Proteins
  • RNA, Messenger
  • Tumor Necrosis Factor-alpha